Inventor · disambiguated record
Fangyong Du
Also filed as: DU FANGYONG
12 granted patents·15 pending applications·25 citations·filing 2003–2024
86Inventor score
Top patents by PatentIndex Score
27 records- 0192US11242395B2Anti-CD137 molecules and use thereofADAGENE INC·Filed 2018·Granted Feb 8, 2022·13 cites·29 claims
- 0288US11359016B2Anti-CTLA4 antibodies and methods of making and using the sameADAGENE INC·Filed 2019·Granted Jun 14, 2022·5 cites·40 claims
- 0386US11859003B2Method for treating cancer using anti-CD137 antibodyADAGENE INC·Filed 2018·Granted Jan 2, 2024·3 cites·18 claims
- 0481US11952681B2Masked activatable CD137 antibodiesADAGENE INC·Filed 2019·Granted Apr 9, 2024·1 cites·43 claims
- 0580US11585014B2Dynamic human antibody light chain librariesADAGENE INC·Filed 2017·Granted Feb 21, 2023·2 cites·23 claims
- 0675US11578426B2Dynamic human heavy chain antibody librariesADAGENE INC·Filed 2017·Granted Feb 14, 2023·1 cites·34 claims
- 0775US2024141046A1Anti-ctla4 antibodies and methods of making and using the sameADAGENE INC·Filed 2023·Application pending·0 cites
- 0874US12503693B2Integrated system for library construction, affinity binder screening and expression thereofADAGENE INC·Filed 2021·Granted Dec 23, 2025·0 cites·6 claims
- 0973US2024150749A1Activatable antibodies and methods of making and using thereofADAGENE INC·Filed 2023·Application pending·0 cites
- 1071US12378319B2Anti-CD137 molecules and use thereofADAGENE INC·Filed 2021·Granted Aug 5, 2025·0 cites·13 claims
- 1170US12385162B2Dynamic human heavy chain antibody librariesADAGENE INC·Filed 2023·Granted Aug 12, 2025·0 cites·32 claims
- 1269US2023287597A1Dynamic human antibody light chain librariesADAGENE INC·Filed 2023·Application pending·0 cites
- 1366US2019241886A1Precision/context-dependent activatable antibodies, and methods of making and using the sameADAGENE INC·Filed 2019·Application pending·0 cites
- 1465US2024279350A1CD40-Binding ProteinsSANOFI SA·Filed 2024·Application pending·0 cites
- 1564US11692036B2Anti-CTLA4 antibodies and methods of making and using the sameADAGENE INC·Filed 2019·Granted Jul 4, 2023·0 cites·28 claims
- 1662US2024262923A1Anti-pd-1×4-1bb binding proteinsGENZYME CORP·Filed 2023·Application pending·0 cites
- 1761US2025257133A1Anti-CD28 Antibodies and Methods of Use ThereofADAGENE PTE LTD·Filed 2023·Application pending·0 cites
- 1861US2025188179A1Anti-cd137 antibodies and methods of making and using the sameADAGENE PTE LTD·Filed 2023·Application pending·0 cites
- 1958US2004023311A1Modulation of angiogenesis through targeting of cysteine oxygenase activityFiled 2003·Application pending·0 cites
- 2057US2024417463A1Anti-cd47 antibodies and methods of use thereofADAGENE PTE LTD·Filed 2022·Application pending·0 cites
- 2156US2016145604A1An Integrated System for Library Construction, Affinity Binder Screening and Expression ThereofADAGENE INC·Filed 2013·Application pending·0 cites
- 2256US2025326860A1Anti-cd3 antibodies and methods of use thereofADAGENE PTE LTD·Filed 2022·Application pending·0 cites
- 2355US12054548B2Anti-PD-L1 antibodies and use thereofADAGENE INC·Filed 2019·Granted Aug 6, 2024·0 cites·11 claims
- 2448US11485977B2Methods and systems for autoinduction of protein expressionADAGENE INC·Filed 2014·Granted Nov 1, 2022·0 cites·14 claims
- 2547US2022089757A1Anti-cd137l antibodies and methods of using sameADAGENE PTE LTD·Filed 2020·Application pending·0 cites
- 2645US2020377608A1Methods for using cd137 ligand as a biomarker for treatment with anti-cd137 antibodyLUO PETER PEIZHI·Filed 2018·Application pending·0 cites
- 2745US2023124669A1Heterodimeric proteins with fc mutationsADAGENE AG·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Fangyong Du files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →